4.87
1.72%
-0.085
시간 외 거래:
4.87
Inmune Bio Inc (INMB) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
50.00%
0.014
|
0.028 | 0.043 | 0.046 | 0.038 |
Operating Expenses
|
31.21%
11.03
|
8.407 | 8.571 | 6.457 | 6.461 |
Interest Income/Expense |
0.357
|
- | - | - | - |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
31.21%
11.03
|
8.407 | 8.571 | 6.457 | 6.461 |
Operating Income/Loss |
31.48%
-11.02
|
-8.379 | -8.528 | -6.411 | -6.423 |
Income/Loss From Continuing Operations Before Tax |
50.00%
0.014
|
0.028 | 0.043 | -6.501 | -6.536 |
Income/Loss From Continuing Operations After Tax |
31.13%
-11.03
|
-8.408 | -8.563 | -6.501 | -6.536 |
Net Income/Loss
|
31.13%
-11.03
|
-8.408 | -8.563 | -6.501 | -6.536 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
130.52K%
18.03
|
0.0138 | 18.01 | 17.95 | 17.95 |
Diluted Average Shares |
130.52K%
18.03
|
0.0138 | 18.01 | 17.95 | 17.95 |
Basic Earnings Per Share |
29.79%
-0.61
|
-0.47 | -0.48 | -0.36 | -0.36 |
Diluted Earnings Per Share |
29.79%
-0.61
|
-0.47 | -0.48 | -0.36 | -0.36 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):